CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model

CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model

Abstract Background Human chronic graft-versus-host disease (CGVHD) shares clinical characteristics with a murine sclerodermatous GVHD (Scl-GVHD, B10.D2 → BALB/c) model that is characterized by skin and lung fibrosis. In this study, bone marrow- or adipose tissue-derived human mesenchymal stem cells...

Full description

Bibliographic Details
Main Authors:	Ji-Young Lim, Da-Bin Ryu, Tae Woo Kim, Sung-Eun Lee, Gyeongsin Park, Hyoung Kyu Yoon, Chang-Ki Min
Format:	Article
Language:	English
Published:	BMC 2020-06-01
Series:	Stem Cell Research & Therapy
Subjects:	Mesenchymal stem cells Chronic graft-versus-host disease Sclerodermatous graft-versus-host disease Allogeneic hematopoietic stem cell transplantation
Online Access:	http://link.springer.com/article/10.1186/s13287-020-01768-7

Similar Items

Optimization of MSC therapeutic strategies for improved GVHD treatment
by: Wang Hanyu, et al.
Published: (2017-11-01)

Regulatory T Cells in GVHD Therapy
by: Wen-wen Guo, et al.
Published: (2021-06-01)

Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
by: Crocchiolo Roberto, et al.
Published: (2021-02-01)

Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage
by: Takahide Ara, et al.
Published: (2021-08-01)

Alemtuzumab as graft-versus-host disease (GVHD) prophylaxis strategy in a developing country: lower rate of acute GVHD, increased risk of cytomegalovirus reactivation
by: C.B. Resende, et al.

Risk Factors for Rehospitalizations after Allogeneic Hematopoietic Stem Cell Transplantation
by: MYu Drokov, et al.
Published: (2019-12-01)

Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation
by: Yuan Song, et al.
Published: (2020-10-01)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
by: Grażyna Kaminska-Winciorek, et al.
Published: (2020-07-01)

The risk factors for cytomegalovirus reactivation following stem cell transplantation
by: Bahareh Valadkhani, et al.
Published: (2016-01-01)

PT-Cy combined with ruxolitinib and tocilizumab prevents aGVHD after haploidentical HSCT
by: BAI Haocheng, et al.
Published: (2020-09-01)

CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations
by: Hiroshi Takahashi, et al.
Published: (2015-01-01)

Mesenchymal stem cells (MSC) delays the occurrence of graft-versus-host disease(GVHD) in the inhibition of hematopoietic stem cells in major histocompatibility complex semi-consistent mice by regulating the expression of IFN-γ/IL-6
by: Ying Wang
Published: (2021-01-01)

Twice-daily intravenous bolus tacrolimus infusion: A safe and effective regimen for graft-versus-host disease prophylaxis
by: Hamza Hashmi, et al.
Published: (2020-12-01)

PHARMACOECONOMIC ANALYSIS OF DIFFERENT METHODS FOR THE TREATMENT OF STEROID-REFRACTORY GRAFT-VERUS-HOST DISEASE: SINGLE-CENTER STUDY
by: I. S. Moiseev, et al.
Published: (2018-03-01)

Correlation of T-Cell Subsets and Hypercholesterolemia of the Donor and Its Association with Acute Graft-versus-Host Disease
by: Monica Magdalena Rivera Franco, et al.
Published: (2019-10-01)

Low cyclosporine concentrations in children and time to acute graft versus host disease
by: Eun Kyung Chung, et al.
Published: (2020-05-01)

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: a Retrospective Study in a Single Center
by: Mei-Fang Hou, et al.
Published: (2015-03-01)

Follicular graft-versus-host disease: A rare manifestation in a patient with the overlap subtype of chronic graft-versus-host disease
by: Yi-Hsin Ho, et al.
Published: (2019-01-01)

De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience
by: Yul Hee Cho, et al.
Published: (2013-09-01)

Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease
by: Ying-Jun Chang, et al.
Published: (2018-12-01)

Multipotent mesenchymal stromal cells application for acute graft versus host disease treatment
by: L. A. Kuzmina, et al.
Published: (2020-09-01)

Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges
by: Mehrdad Hefazi, et al.
Published: (2021-09-01)

The role of dendritic cells in graft-versus-tumor effect
by: Pavan eReddy, et al.
Published: (2014-02-01)

Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation
by: Melissa Mavers, et al.
Published: (2017-07-01)

Anti-tumor necrosis factor-a for the treatment of steroid-refractory acute graft-versus-host disease
by: M.C. Nogueira, et al.
Published: (2007-12-01)

Current Preventions and Treatments of aGVHD: From Pharmacological Prophylaxis to Innovative Therapies
by: Sina Naserian, et al.
Published: (2020-12-01)

Effect of Early Post-Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation
by: Nidhi Sharma, et al.
Published: (2021-02-01)

SEVERE (GRADE III-IV) ACUTE GRAFT VERSUS HOST DISEASE AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Irena Preložnik-Zupan, et al.
Published: (2002-09-01)

Mouse Models of Antigen Presentation in Hematopoietic Stem Cell Transplantation
by: Motoko Koyama, et al.
Published: (2021-09-01)

Extracorporeal photopheresis in the treatment of graft-versus-host disease
by: I. V. Guz, et al.
Published: (2016-03-01)

MicroRNAs: the missing link in the biology of graft-versus-host disease?
by: Sadaf eAtarod, et al.
Published: (2013-12-01)

Comparative Study of Mycophenolate Mofetil and Methotrexate in Graft-Versus-Host Disease Prophylaxis in Adult Recipients of Related and Unrelated Allo-HSCT
by: IS Moiseev, et al.
Published: (2018-12-01)

Late Post-Operative Occurrence of Dentin Hypersensitivity in Adult Patients Following Allogeneic Hematopoietic Stem Cell Transplantation—A Preliminary Report
by: Agnieszka Bogusławska-Kapała, et al.
Published: (2021-08-01)

Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation
by: Yanmin Zhao, et al.
Published: (2021-06-01)

GVHD Pathogenesis, Prevention and Treatment: Lessons From Humanized Mouse Transplant Models
by: Nicholas J. Hess, et al.
Published: (2021-07-01)

MiR-146a and miR-155 Expression Levels in Acute Graft-Versus-Host Disease Incidence
by: Sadaf eAtarod, et al.
Published: (2016-03-01)

Hitting the Holy Grail of Hematopoietic Cell Transplantation with Naive T-Cell Depleted Allografts—Graft Engineered Hematopoietic Stem Cell Transplant
by: Riad El Fakih, et al.
Published: (2017-08-01)

Regulatory B cells promote graft-versus-host disease prevention and maintain graft-versus-leukemia activity following allogeneic bone marrow transplantation
by: Yue Hu, et al.
Published: (2017-03-01)

GVHD-derived plasma as a priming strategy of mesenchymal stem cells
by: Amandda Évelin Silva-Carvalho, et al.
Published: (2020-04-01)

Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?
by: Martino Introna, et al.
Published: (2020-12-01)